Insmed (INSM) PT Raised to $213 at BofA Securities

March 23, 2026 12:48 PM

BofA Securities analyst Jason Zemansky raised the price target on Insmed (NASDAQ: INSM) to $213.00 (from $211.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found